Less ventilator-associated pneumonia after oral decontamination with chlorhexidine; a randomised trial;Minder beademingspneumonieën door orale decontaminatie met chloorhexidine; gerandomiseerde trial

Nederlands Tijdschrift voor Geneeskunde

Volumn 152, Issue 13, 2008, Pages 752-759

  Koeman, M ^a,h   Van Der Ven, A J A M ^b   Hak, E ^a   Joore, J C A ^a   Kaasjager, H A H ^c   De Smet, A M G A ^a   Ramsay, G ^d   Dormans, T P J ^d   Aarts, L P H J ^e   De Bel, E E ^f   Hustinx, W N M ^g   Van Der Tweel, I ^a   Hoepelman, I M ^a   Bonten, M J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RIJNSTATE HOSPITAL   (Netherlands)

^d Zuyderland Medical Centre   (Netherlands)

^e ST ANTONIUS HOSPITAL   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g DEPARTMENT OF SURGERY   (Netherlands)

^h NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; COLISTIN; PLACEBO;

ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; VENTILATOR ASSOCIATED PNEUMONIA;

ADMINISTRATION, TOPICAL; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CHLORHEXIDINE; COLISTIN; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INTENSIVE CARE; LENGTH OF STAY; MALE; MIDDLE AGED; MOUTH; OROPHARYNX; PLACEBOS; PNEUMONIA, BACTERIAL; TIME FACTORS; TRACHEA; VENTILATORS, MECHANICAL;

EID: 41749088675     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867-903.
2. Bergmans DCJJ, Bonten MJM, Gaillard CA, Tiel FH van, Geest S van der, Leeuw PW de, et al. Indications for antibiotic use in ICU patients. J Antimicrob Chemother. 1997;39:527-35.
3. Johanson jr WG, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with Gram-negative bacilli. Ann Intern Med. 1972;77:701-6.
4. Bonten MJM, Gaillard CA, Leeuw PW de, Stobberingh EE. Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia. Clin Infect Dis. 1997;24:309-19.
5. Pugin J, Auckenthaler R, Lew DP, Suter PM. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. JAMA. 1991;265:2704-10.
6. Bergmans DC, Bonten MJM, Gaillard CA, Paling JC, Geest S van der, Tiel FH van, et al. Prevention of ventilator-associated pneumonia by oral decontamination. Am J Respir Crit Care Med. 2001;164:382-8.
7. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003. MMWR Recomm Rep. 2004;53:1-36.
8. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998;129:433-40.
9. Hammond SA, Morgan JR, Russell AD. Comparative susceptibility of hospital isolates of gram-negative bacteria to antiseptics and disinfectants. J Hosp Infect. 1987;9:255-64.
10. Katz SL, Ho SL, Coates AL. Nebulizer choice for inhaled colistin treatment in cystic fibrosis. Chest. 2001;119:250-5.
11. DeRiso 2nd AJ, Ladowski JS, Dillon TA, Justice JW, Peterson AC. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest. 1996;109:1556-61.
12. Bergmans DCJJ, Bonten MJM, Leeuw PW de, Stobberingh EE. Reproducibility of quantitative cultures of endotracheal aspirates from mechanically ventilated patients. J Clin Microbiol. 1997;35:796-8.
13. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic 'blind' bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991;143(5 Pt 1):1121-9.
14. MPS research Unit. PEST 4: operating manual. Reading: University of Reading; 2000.
15. Russell AD, Day MJ. Antibacterial activity of chlorhexidine. J Hosp Infect. 1993;25:229-38.
16. Linden PK, Kusne S, Coley K, Fontes P, Kramer DJ, Paterson D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis. 2003;37:e154-60.
17. Houston S, Hougland P, Anderson JJ, LaRocco M, Kennedy V, Gentry LO. Effectiveness of 0.12% Chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care. 2002;11:567-70.
18. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogué S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients. Lancet. 1999;354:1851-8.
19. Nieuwenhoven CA van, Vandenbroucke-Grauls C, Tiel FH van, Joore HC, Strack van Schijndel RJM, Tweel I van der, et al. Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia. Crit Care Med. 2006;34:396-402.
20. Jonge E de, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet. 2003;362:1011-6.
21. Gastinne H, Wolff M, Lachatre G, Boiteau P, Savy FP. Antibiotic levels in bronchial tree and in serum during selective digestive decontamination. Intensive Care Med. 1991;17:215-8.
22. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections. Chest. 1999;115:462-74.